Strong evidence from independent research study illustrates Sensodetect’s ability to detect ADHD and Schizophrenia
A large independent study performed in University Hospital in Uppsala, Sweden has illustrated the validity of the SensoDetect technology (ABR profiling test).The results show that patients with ADHD and Schizophrenia can be discriminated versus a healthy control group by using the SensoDetect technology. This is proven with very high sensitivity and specificity (Schizophrenia: Specificity 93,1% & Sensitivity 84,6%. ADHD: Specificity: 91,4% & Sensitivity 87,5%). The main research team members are Chief Physician Eva Juselius Baghdassarian, Chief Physician Maria Nilsson Markhed and Chief